Hospira Inc. recalls KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Fore
Recalled July 22, 2015 · FDA recall D-1241-2015 · Hospira
Hazard
Crystallization; identified as calcium salt of Ketorolac · FDA Class II
Units
12,460,975 vials(Hospira label); 3,016,500 vials (NOVAPLUS label)
Sold at
Nationwide, Puerto Rico, Guam, Canada and Singapore
Description
Crystallization; identified as calcium salt of Ketorolac
Product
KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49
Manufacturer(s)
Hospira Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →